Chinese Medical Sciences Journal ›› 2022, Vol. 37 ›› Issue (3): 240-45.doi: 10.24920/004167
• All for People’s Health——Our Decade:Special Reports • Previous Articles Next Articles
A Decade of Scientific and Technological Innovation at Chinese Academy of Medical Sciences & Peking Union Medical College: Retrospect and Prospect
Taolian Yang1, Hua Zhong2, Wei Wang1, *(
), Jianwei Wang3, *()
- 1Administration Office of Science and Technology Projects, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
2Institute of Medical Information, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100020, China
3Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
-
Received:2022-09-13Accepted:2022-09-14Published:2022-09-30 -
Contact:Wei Wang,Jianwei Wang E-mail:wangwei@cams.cn;wangjw28@163.com
| Focusing on the reform initiatives of Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC) in medical scientific and technological innovation from perspectives of deepening the reform and optimizing the ecosystem of science and technology innovation, this article summarizes the highlights of CAMS & PUMC’s efforts in safeguarding people’s health and promoting the Healthy China 2030 strategy through scientific and technological innovation in the fields including basic research, disease prevention and treatment, medical technology in the past ten years. |
Cite this article
Taolian Yang, Hua Zhong, Wei Wang, Jianwei Wang. A Decade of Scientific and Technological Innovation at Chinese Academy of Medical Sciences & Peking Union Medical College: Retrospect and Prospect[J].Chinese Medical Sciences Journal, 2022, 37(3): 240-45.
share this article
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
| 1. | Chinse Academy of Medical Sciences. Science and Technology Evaluation Metrics. News overview. Available from: http://top100.imicams.ac.cn/news. Accessed: September 30, 2022. |
| 2. |
Wang C, Zhai XM, Zhang XQ, et al. Gene-edited babies: Chinese Academy of Medical Sciences’ response and action. The Lancet 2019; 393(10166): 25-6. doi: 10.1016/S0140-6736(18)33080-0.
doi: 10.1016/S0140-6736(18)33080-0 |
| 3. |
Chen K, Liu J, Liu SX, et al. Methyltransferase SETD2-mediated methylation of STAT1 is critical for interferon antiviral activity. Cell 2017; 170(3): 492-506.e14. doi: 10.1016/j.cell.2017.06.042.
doi: S0092-8674(17)30761-4 pmid: 28753426 |
| 4. |
Wang P, Xu JF, Wang YJ, et al. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism. Science 2017; 358(6366):1051-5. doi: 10.1126/science.aao0409.
doi: 10.1126/science.aao0409 pmid: 29074580 |
| 5. |
Xu XQ, Xu J, Wu JC, et al. Phosphorylation-mediated IFN-γR2 membrane translocation is required to activate macrophage innate response. Cell 2018;175(5):1336-51.e17. doi: 10.1016/j.cell.2018.09.011.
doi: S0092-8674(18)31183-8 pmid: 30318148 |
| 6. |
Jiang MH, Zhang SK, Yang ZH, et al. Self-recognition of an inducible host lncRNA by RIG-I feedback restricts innate immune response. Cell 2018; 173(4): 906-19. doi: 10.1016/j.cell.2018.03.064.
doi: S0092-8674(18)30396-9 pmid: 29706547 |
| 7. |
Han YM, Liu QY, Hou J, et al. Tumor-induced generation of splenic erythroblast-like Ter-Cells promotes tumor progression. Cell 2018; 173(3):634-48.e12. doi: 10.1016/j.cell.2018.02.061.
doi: S0092-8674(18)30238-1 pmid: 29606356 |
| 8. |
Shen QC, Zhang Q, Shi Y, et al. Tet 2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation. Nature 2018; 554(7690):123-7. doi: 10.1038/nature25434.
doi: 10.1038/nature25434 |
| 9. |
Liu Y, You YL, Lu ZK, et al. N6-methyladenosine RNA modification-mediated cellular metabolism rewiring inhibits viral replication. Science 2019; 365(6458):1171-6. doi: 10.1126/science.aax4468.
doi: 10.1126/science.aax4468 pmid: 31439758 |
| 10. |
Wang L, Wen MY, Cao XT. Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses. Science 2019; 365(6454):eaav075. doi: 10.1126/science.aav0758.
doi: 10.1126/science.aav0758 |
| 11. |
Liu YY, Liang XY, Dong WQ, et al. Tumor-repopulating cells induce PD-1 expression in CD8+ T Cells by transferring kynurenine and AhR activation. Cancer Cell 2018; 33(3):480-94.e7. doi: 10.1016/j.ccell.2018.02.005.
doi: 10.1016/j.ccell.2018.02.005 |
| 12. |
Liu YY, Fang YL, Chen XF, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome. Sci Immunol 2020; 5(43):1-13. doi: 10.1126/sciimmunol.aax7969.
doi: 10.1126/sciimmunol.aax7969 |
| 13. |
Zhou J, Xu JY, Zhang LL, et al. Combined single-cell profiling of lncRNAs and functional screening reveals that H 19 is pivotal for embryonic hematopoietic stem cell development. Cell Stem Cell 2019; 24(2):285-98. doi: 10.1016/j.stem.2018.11.023.
doi: S1934-5909(18)30559-9 pmid: 30639035 |
| 14. |
Dong F, Hao S, Zhang S, et al. Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis. Nature Cell Biol 2020; 22(6):630-9. doi: 10.1038/s41556-020-0512-1.
doi: 10.1038/s41556-020-0512-1 |
| 15. |
Wang FJ, He JH, Liu SQ, et al. Comprehensive RNA editome reveals that edited Azin 1 partners with DDX1 to enable hematopoietic stem cell differentiation. Blood 2021; 138(20):1939-52. doi: 10.1182/blood.2021011314.
doi: 10.1182/blood.2021011314 |
| 16. |
Li RY, Di L, Li J, et al. A body map of somatic mutagenesis in morphologically normal human tissues. Nature 2021; 597(7876):398-403. doi: 10.1038/s41586-021-03836-1.
doi: 10.1038/s41586-021-03836-1 |
| 17. |
Yang XL, Li JX, Hu DS, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (Prediction for ASCVD Risk in China). Circulation 2016; 134(19):1430-40. doi: 10.1161/CIRCULATIONAHA.117.027318.
doi: 10.1161/CIRCULATIONAHA.117.027318 pmid: 27682885 |
| 18. |
Lu XF, Liu ZY, Cui QM, et al. A polygenic risk score improves risk stratification of coronary artery disease: a large-scale prospective Chinese cohort study. Eur Heart J 2022; 43(18):1702-+. doi: 10.1093/eurheartj/ehac093.
doi: 10.1093/eurheartj/ehac093 pmid: 35195259 |
| 19. |
Zhang WL, Zhang SY, Deng Y, et al. Trial of intensive blood-pressure control in older patients with hypertension. New Engl J Med 2021; 385(9):1268-79. doi: 10.1056/NEJMoa2111437.
doi: 10.1056/NEJMoa2111437 |
| 20. |
Huang KY, Liang FC, Yang XL. Long term exposure to ambient fine particulate matter and incidence of stroke BMJ: Bri Med J 2020; 368(8229):59. doi: 10.1136/bmj.16720.
doi: 10.1136/bmj.16720 |
| 21. |
Xu B, Tu SX, Song L, et al. Angiographic quantitative flow ratio-guided coronary intervention (FAVOR III China): a multicentre, randomised, sham-controlled trial. Lancet 2021; 398(10317): 2149-59. doi: 10.1016/S0140-6736(21)02248-0.
doi: 10.1016/S0140-6736(21)02248-0 pmid: 34742368 |
| 22. |
Xiao D, Chen ZM, Wu SN, et al. Prevalence and risk factors of small airway dysfunction, and association with smoking, in China: findings from a national cross-sectional study. from a national cross-sectional study. The Lancet Respira Med 2020; 8(11):1081-93. doi: 10.1016/S2213-2600(20)30155-7.
doi: 10.1016/S2213-2600(20)30155-7 |
| 23. |
Chen WQ, Zheng RS, Baade P, et al. Cancer Statistics in China, 2015. CA: Cancer J Clin 2016; 66(2):115-32. doi: 10.3322/caac.21338.
doi: 10.3322/caac.21338 |
| 24. |
Zeng HM, Chen WQ, Zheng RS, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. The Lancet Global Health 2018; 6(5):e555-e567. doi: 10.1016/S2214-109X(18)30127-X.
doi: 10.1016/S2214-109X(18)30127-X |
| 25. |
Chen WQ, Xia CF, Zheng RS, et al. Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment. The Lancet Global Health 2019; 7(2):e257-e269. doi: 10.1016/S2214-109X(18)30488-1.
doi: 10.1016/S2214-109X(18)30488-1 |
| 26. |
Zhang JJ, Zhao YQ, Dai Yi, et al. Effectiveness of high-risk human papillomavirus testing for cervical cancer screening in China: a multicenter, open-label, randomized clinical trial. JAMA oncology 2021; 7(2):263-70. doi: 10.1001/jamaoncol.2020.6575.
doi: 10.1001/jamaoncol.2020.6575 pmid: 33377903 |
| 27. | Ministry of Science and Technology of the People’s Republic of China. 2019 National Science and Technology Progress Award Winning Projects Catalogue. Available from: https://www.most.gov.cn/ztzl/gjkxjsjldh/jldh2019/jldh19jlgg/202001/t20200103_150916.html. Accessed:January 10, 2020. |
| 28 |
Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 2013; 381(9882):2024-32. doi: 10.1016/S0140-6736(13)61049-1.
doi: 10.1016/S0140-6736(13)61049-1 |
| 29. |
Li RC, Liu LD, Mo ZJ, et al. An inactivated enterovirus 71 vaccine in healthy children. New Engl J Med 2014; 370(9):829-37. doi: 10.1056/NEJMoa1303224.
doi: 10.1056/NEJMoa1303224 |
| 30. |
Xue J, Chong HH, Zhu YM, et al. Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide. Cell 2021; 185(1):131-44. doi: 10.1016/j.cell.2021.11.032.
doi: 10.1016/j.cell.2021.11.032 pmid: 34919814 |
| 31. | Ministry of Science and Technology of the People’s Republic of China. 2020 National Science and Technology Progress Award Winning Projects Catalogue. Available from: https://www.most.gov.cn/cxfw/kjjlcx/kjjl2020/202111/t20211103_177782.html. Released:November 2, 2021; accessed: September 10, 2022. |
| 32. | Ministry of Science and Technology of the People’s Republic of China. Catalog of the 2017 National Science and Technology Progress Award Winning Projects. Available from: https://www.most.gov.cn/ztzl/gjkxjsjldh/jldh2017/jldh17jlgg/201801/t20180103_137374.html. Released: January 8, 2018; accessed: September 10, 2022. |
| 33. |
Ren LL, Wang YM, Wu ZQ, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chin Med J 2020; 133(9): 1015-24. doi: 10.1097/CM9.0000000000000722.
doi: 10.1097/CM9.0000000000000722 |
| 34. |
Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. The Lancet 2020; 395(10223):470-3. doi: 10.1016/S0140-6736(20)30185-9.
doi: 10.1016/S0140-6736(20)30185-9 |
| 35. |
Pang XH, Ren LL, Wu SS, et al. COVID-19 Field Response Group, COVID-19 Laboratory Testing Group. Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing. Natl Sci Rev 2020; 7(12):1861-64. doi: 10.1093/nsr/nwaa264.
doi: 10.1093/nsr/nwaa264 pmid: 34676083 |
| 36. |
Wang YM, Zhang DY, Du GH, et al. Remdesivir in adults with severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial. The Lancet 2020; 395(10236):1569-78. doi: 10.1016/S0140-6736(20)31022-9.
doi: 10.1016/S0140-6736(20)31022-9 |
| 37. |
Guo L, Wang G, Wang YM, et al. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study. The Lancet Microbe 2022; 3(5): E348-56. doi: 10.1016/S2666-5247(22)00036-2.
doi: 10.1016/S2666-5247(22)00036-2 |
| 38. |
Li L, Zhang W, Hu Yu, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life-threatening COVID-19: a randomized clinical trial. JAMA 2020; 324(5): 460-70. doi: 10.1001/jama.2020.10044.
doi: 10.1001/jama.2020.10044 pmid: 32492084 |
| 39. |
He ZY, Ren LL, Yang JT, et al. Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. The Lancet 2021; 397(10279): 1075-84. doi: 10.1016/S0140-6736(21)00238-5.
doi: 10.1016/S0140-6736(21)00238-5 |
| 40. |
Chen SM, Zhang ZJ, Yang JT, et al. Fangcang shelter hospitals: a novel concept for responding to public health emergencies. The Lancet 2020; 395(10232): 1305-14. doi: 10.1016/S0140-6736(20)30744-3.
doi: 10.1016/S0140-6736(20)30744-3 |
| [1] | Ning Xiaohong,Li Jie,Xiang Yirong. Running a Volunteer Program for Palliative Care in a Chinese Hospital: Our Practice and Experience [J]. Chinese Medical Sciences Journal, 2018, 33(4): 216-220. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
